Alkem Laboratories Limited is a top Indian pharma house having a significant presence of branded generics and speciality medicines. Headquartered in Mumbai, Alkem has operations spread across India and the international markets including the United States. The company deals in high quality and cheap medicines, and it continues to build its position through research, manufacturing excellence, and international expansion.
Alkem Laboratories – Quick Overview
| Particular | Details |
| Company Name | Alkem Laboratories Limited |
| Type | Public Company |
| Industry | Pharmaceuticals |
| Founded | 1973 |
| Founder | Samprada Singh |
| Headquarters | Mumbai, Maharashtra, India |
| Chairman | Basudeo Narayan Singh |
| CEO | Vikas Gupta |
| Managing Director | Sandeep Singh |
| Listed On | NSE: ALKEM, BSE: 539523 |
| Employees | 20,000+ |
| Manufacturing Units | 21 (19 in India, 2 in the US) |
| Official Website | alkemlabs.com |
Net Worth and Market Cap
Alkem Laboratories has developed solid financial basics over decades of steady expansion. The company’s net worth, measured through total equity, stands at approximately ₹12,433 crore as of 2025.
Alkem’s market capitalization is estimated to be around ₹85,000 crore and this is indicative of high investor confidence, consistent revenue growth and a stable product portfolio. The company reported revenue of ₹12,964 crore and net profit of ₹2,165 crore in 2025, further strengthening the company’s valuation in the Indian stock market.
Corporate Leadership
Alkem Laboratories is run by experienced and stable leadership. Co-founder of the company, Basudeo Narayan Singh is the Chairman and the strategy giver. Vikas Gupta leads the organisation as Chief Executive Officer and drives performance operationally and in terms of global strategy. Sandeep Singh, son of the founder, Samprada Singh, is the Managing Director and instrumental and important to the long term growth initiatives.
The Singh family remains the major promoting group, with public shareholders holding the rest ownership.
Overview of Services
Alkem Laboratories develops, manufactures, and markets a wide range of pharmaceutical products. Its portfolio contains branded generic medicines, speciality medicines, over-the-counter products, vaccines, diagnostics, nutraceuticals, animal health products and contact lens solutions.
The company has a good presence in different therapeutic areas including anti-infectives, Gastroenterology, Cardiology, Neurology, Diabetology, and Pain management. Alkem also invests heavily in research and development, especially for ANDA filing to regulated markets such as the US.
Scale of Operations
Alkem Laboratories works at a large scale in domestic and international markets. The company has 21 manufacturing facilities with approvals from major global regulators like US FDA and UK MHRA. Alkem exports products in more than 40 countries and has a good distribution network across India.
With an expanding footprint in the global markets and a strong pipeline, Alkem Laboratories remains one of the leading pharmaceutical companies in India.
